Subscribe To
Myriad genetics (mygn) secures key milestones in illumina tie-up
Myriad Genetics (MYGN) achieves significant milestones in its partnership with Illumina....
September 20, 2023, 9:01 am
Mainz biomed to present at the cantor fitzgerald global healthcare conference
BERKELEY, Calif. and MAINZ, Germany, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a m...
September 20, 2023, 3:01 am
Ligand (lgnd) to spin out pelican subsidiary, updates '23 view
Ligand (LGND) intends to spin out and merge its subsidiary Pelican with Primordial Genetics to form a n...
September 19, 2023, 3:02 pm
Myriad genetics' (mygn) new deal to use mrd testing platform
Myriad Genetics (MYGN) announces a collaboration with Memorial Sloan Kettering Cancer Center to study t...
September 19, 2023, 9:01 am
eneti inc. signs vessel reservation contract for newbuild wtiv
MONACO, Sept. 18, 2023 (GLOBE NEWSWIRE) — eneti Inc. (NYSE:NETI) (the “Company”) announced today ...
September 18, 2023, 11:54 am
Why shares of dyne therapeutics fell this week
Dyne Therapeutics is a clinical-stage biotech. The company focuses on rare genetic disorders....
September 15, 2023, 1:52 pm
Biohacking market poised to attain usd 83 billion by 2032 | north america hold – highest revenue share of 39%
The market for genetic modification kits is growing because more and more companies are developing thes...
September 13, 2023, 1:37 pm
Why shares of rocket pharmaceuticals are taking off on wednesday
The company also announced a public stock offering that it said was worth $175 million. The clinical-stage biotech focuses on g...
September 13, 2023, 11:56 am
Adaptive announces launch of epic integration for clonoseq®
The Adaptive-Epic integration will provide clinicians and patients with easier access to minimal residual disease (MRD) monitoring in blood cancers SE...
September 13, 2023, 11:30 am
Wave life sciences: excellent early data, major collaborations, needs cash
Wave Life Sciences Ltd. develops stereopure oligonucleotides targeting disease-causing genetic mutation...
September 12, 2023, 5:09 pm
Here's why you should retain myriad genetics (mygn) stock now
Investors are optimistic about Myriad Genetics (MYGN) on improvement in testing volume across all its b...
September 12, 2023, 12:50 pm
Dyne therapeutics: muscle disease oligo therapy developer in early stages
Dyne Therapeutics is developing treatments for genetically driven muscle diseases, focusing on Myotonic...
September 10, 2023, 5:25 am
Pharming group: pipeline progresses with apds phase 3 initiation
Pharming Group NV is a biotechnology firm known for its unique approach to addressing rare and genetic ...
September 9, 2023, 12:30 pm
Cathie wood's buying these 3 stocks hand over fist
Cathie Wood recently bought shares of Beam Therapeutics, a clinical-stage drugmaker testing out a new way to edit troublesome genes. Ark Invest also a...
September 8, 2023, 7:23 am
Myriad genetics: frα addition further diversifies portfolio
Myriad Genetics is a leading molecular diagnostic company that focuses on developing and marketing pred...
September 7, 2023, 10:52 pm
Mustang bio to participate in upcoming september 2023 investor conferences
WORCESTER, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focu...
September 7, 2023, 8:15 am
Myriad genetics named to 2023 best workplaces in health care list by fortune and great place to work
SALT LAKE CITY, Sept. 06, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in g...
September 6, 2023, 8:05 pm
Solid biosciences to participate at upcoming investor conferences
CHARLESTOWN, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing g...
September 5, 2023, 12:56 pm
Exel vs. ilmn: which stock is the better value option?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider eit...
September 5, 2023, 12:47 pm
Is this underfollowed genetic diagnostics stock a buy for growth investors?
Veracyte's revenue sharply rose in the second quarter. The company is moving toward profitability....
September 2, 2023, 6:15 am